Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma

D.J. Betting, S.A. Hurvitz, K.K. Steward, R.E. Yamada, K. Kafi, N. van Rooijen, J.M. Timmerman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)534-543
JournalJournal of Immunotherapy
Volume35
Issue number7
DOIs
Publication statusPublished - 2012

Cite this

Betting, D. J., Hurvitz, S. A., Steward, K. K., Yamada, R. E., Kafi, K., van Rooijen, N., & Timmerman, J. M. (2012). Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma. Journal of Immunotherapy, 35(7), 534-543. https://doi.org/10.1097/CJI.0b013e318261e679